Vascular Infection, Graft/Endograft Infection, Infected Aneurysm, and Aortoenteric Fistula

13.1Suspect and classify infection without a single-test shortcut

Vascular infection should be approached as a management problem before it is approached as a naming problem. The same patient may carry overlapping labels—vascular graft infection, endograft infection, infected native aneurysm, endovascular infection, soft-tissue infection overlying a bypass, or aortoenteric fistula—and the practical question is whether infection involves prosthetic material, the native arterial wall, adjacent bowel, or only superficial tissue. The AHA framework treats graft infection, infected aneurysm, and endovascular infection as one multidisciplinary domain crossing surgery, imaging, microbiology, and antimicrobial care; newer ESVS-aligned terminology further reinforces the need for consistent definitions when communicating with infectious diseases, radiology, anesthesia, and referring teams. Vascular Graft Endograft 2026 · Vascular Graft Infections 2016

For trainees, the most important diagnostic habit is to avoid “ruling out” infection with one negative test or “ruling it in” with one abnormal image. ESVS guidance uses the MAGIC framework as the reference diagnostic scheme, and MAGIC requires integration of clinical, operative, microbiologic, and imaging inputs rather than dependence on a single finding. European Society Vascular 2020 In a patient with prior aortic or peripheral prosthetic reconstruction, classification should therefore be staged: suspected infection, probable/diagnosed infection, presence or absence of fistula, native aneurysm versus prosthetic infection, and whether complete source control appears physiologically possible.

MAGIC performs well as a structured language but must be interpreted carefully. Prospective validation showed very high sensitivity but limited baseline specificity, and specificity improved when “suspected” cases were not automatically counted as infected; a later retrospective validation showed excellent specificity, with sensitivity changing depending on how suspected cases were handled. Diagnosis prosthetic vascular 2026 · Validation MAGIC Criteria 2021 This matters at the bedside: a patient with equivocal imaging and low clinical probability should not be committed prematurely to explantation, but a patient with sepsis, perigraft collection, positive operative cultures, or fistula physiology should not be reassured by imperfect classification language.

Endograft infection deserves particular vigilance because it is uncommon but dangerous and often delayed. Meta-analysis after EVAR reported an incidence around 0.6%, substantial early mortality, and a mean interval to diagnosis of about 25 months; a large multicenter series found a similar mean diagnostic interval of 22 months and aortic fistula in more than one quarter of presentations. Endograft Infection After 2017 · Treatment outcomes aortic 2016 Surveillance encounters long after EVAR or TEVAR should therefore still ask whether new constitutional symptoms, unexplained inflammation, perigraft gas or fluid, or bleeding could represent infection rather than routine late aneurysm follow-up.

Peripheral prosthetic vascular graft infection belongs in the same diagnostic discipline, even though the consequences and operative choices differ from the aorta. Surgical-site and soft-tissue infection guidance helps frame empiric management when infection overlies or abuts a reconstruction, but deep prosthetic involvement moves the problem into vascular graft infection territory, where source control, reconstruction planning, and organism-directed therapy become decisive. Practice guidelines diagnosis 2014 Contemporary peripheral PVGI cohort evidence supports treating extremity graft infection as part of the same source-control and follow-up framework rather than as a simple wound problem. Peripheral Prosthetic Vascular

13.2Microbiology and imaging must answer the operative question

Microbiology is useful only when it changes management. Empiric therapy should be chosen from the graft site and likely flora, then narrowed to operative or culture data when available. Recent Delphi consensus for vascular graft and endograft infection anchors empiric therapy in anatomic site and expected organisms; for abdominal disease without aortoenteric fistula, the intended empiric spectrum includes gram-positive cocci, gram-negative bacilli, and anaerobes, with narrowing once cultures define the target. Treatment follow-up vascular 2025

Appropriate early antimicrobial coverage is not a cosmetic detail. In a 10-year cohort of hospitalized vascular graft infection, appropriate empirical antimicrobial therapy independently predicted survival, while most patients still underwent surgery. Long-term Prognosis Following 2022 The lesson for the surgeon is that antibiotics are started urgently and intelligently, but they are also a bridge to culture-directed care and operative decision-making; “broad” should not mean “unexamined,” and “culture-negative” should not mean “no infection” when the operative and imaging pattern is convincing.

Pathogen identity also shapes prognosis and diagnostic suspicion. Candida aortic-graft infection adds a distinct fungal-organism category with different counseling implications from non-Candida infection. Outcomes Candida Non-Candida 2023 Uncommon fastidious organisms such as Actinomyces add another reason to obtain deep cultures and to revisit antimicrobial assumptions when the clinical course does not match standard bacterial infection. Actinomyces spp. Prosthetic 2023

Imaging should be ordered to answer a surgical question: Is there perigraft infection? Is there an infected aneurysm? Is bowel involved? Is there a collection that can be drained? Is reconstruction likely to be possible? CTA is usually the anatomic starting point, but its pooled diagnostic performance for vascular graft infection is modest; meta-analysis reported higher sensitivity and specificity for FDG-PET/CT and white-cell SPECT/CT than for CTA. Diagnostic Imaging Vascular 2018 Thus, CTA maps the vessel and operative field, while nuclear or hybrid imaging can strengthen or weaken the infection diagnosis when CT is equivocal.

FDG-PET/CT is powerful but not self-interpreting. Meta-analysis of prosthetic vascular graft infection found high sensitivity and moderate specificity, with non-specific perigraft uptake possible for months after implantation. Prosthetic vascular graft 2022 Aortic endograft infection studies similarly support PET/CT when CT is ambiguous, but reproducibility depends on standardized preparation and scan timing; early postoperative uptake should not be overcalled. F FDG PET 2022 For infected native aortic aneurysm, small-series data show PET-CT uptake can support diagnosis and response monitoring, but no single SUV threshold should be treated as definitive. Value F-FDG-PET-CT management 2021

Do not use quantitative imaging as a survival oracle. In a cohort of aortic graft and endograft infection, neither baseline clinical characteristics nor quantitative FDG-PET imaging metrics reliably predicted in-hospital mortality or longer-term survival, despite PET’s diagnostic value. Aortic Vascular Graft Patient selection for excision, in-situ reconstruction, drainage, suppression, or palliation must therefore combine anatomy, microbiology, physiology, frailty, fistula status, and the feasibility of source control rather than relying on a scan number.

13.3Antibiotics and source control are not interchangeable

Antibiotics and source control solve different problems. Antimicrobials reduce microbial burden, treat bacteremia, and protect the patient while diagnosis and reconstruction are organized; they do not remove infected prosthetic material, close a fistula, or debride necrotic tissue. Conversely, operation without appropriate antimicrobial coverage leaves the patient exposed to persistent infection and recurrent sepsis. The practical sequence is early empiric therapy, culture acquisition whenever possible, operative or drainage planning, and narrowing or suppressive decisions after source control is defined. Treatment follow-up vascular 2025 · Long-term Prognosis Following 2022

For abdominal aortic graft infection, the strongest operative principle remains removal of infected material when the patient can tolerate it. A 2024 network meta-analysis found that complete removal with in-situ repair had the lowest reinfection rate and superior midterm survival compared with extra-anatomic bypass; a 2023 review comparing removal with preservation showed similar early mortality but lower one-year mortality in a small, highly selected preservation cohort, underscoring that preservation is a selection strategy, not proof of equivalence. Surgical management abdominal 2024 · Clinical outcome graft 2023

In-situ reconstruction is not a single operation. Available conduit choices include autogenous femoral vein reconstruction, cryopreserved allograft, antibiotic-bonded prosthetic graft, and silver-impregnated prosthetic graft, each carrying tradeoffs in biologic infection resistance, durability, availability, and operative burden. Meta-analysis suggests broadly similar reinfection rates across conduits, with autogenous vein offering strong biologic resistance; comparative data show femoral-vein neoaortoiliac reconstruction and cryopreserved aortic allograft can both be reasonable for fit patients, although morbidity remains high and critically ill patients may not tolerate these reconstructions. Meta-Analysis Outcomes After 2018 · Neoaortoiliac system cryopreserved

Adjuncts are part of source control, not decoration. Aortic infection management combines aggressive debridement, biologic or infection-resistant reconstruction, vascularized tissue coverage, and prolonged antibiotic therapy; omental coverage is specifically used to improve infection clearance and healing. Infections aorta A contemporary in-situ reconstruction series using femoral-vein NAIS and cryopreserved homograft reported acceptable perioperative mortality but poor longer-term outcomes and frequent reintervention, with gram-negative and drug-resistant organisms prominent in recurrence. Outcomes Following Situ 2023 Trainees should therefore plan the whole reconstruction field—debridement, conduit, coverage, and postoperative surveillance—rather than focusing only on the proximal and distal anastomoses.

Conservative or graft-preserving care has a role, but it should be named honestly. Percutaneous drainage may serve as a conservative or palliative option for selected aortic graft infections, and contemporary thoracic vascular graft infection data support antibiotic-based nonoperative or graft-preserving management as a reasonable alternative for patients who cannot tolerate complete excision. Outcomes conservative treatment · Percutaneous Drainage Aortic 2022 These strategies are not “no treatment”; they require drainage when feasible, prolonged antimicrobial planning, careful counseling about relapse, and explicit recognition that retained infected material may remain the driver of future sepsis.

Emergency presentation changes the risk calculation. In a single-center abdominal graft infection cohort, in-situ reconstruction was associated with fewer reinfections and better overall survival than extra-anatomic bypass or conservative treatment, while emergency operative timing was the independent predictor of early mortality. Management Clinical Outcome The bedside implication is to stabilize physiology when possible, but not to mistake repeated temporizing maneuvers for definitive care in a patient whose anatomy and fitness still allow source control.

13.4Aortoenteric fistula and infected aneurysm are danger lanes

Aortoenteric fistula is a hemorrhage-and-sepsis problem, not simply a gastrointestinal bleeding diagnosis. Secondary aortoenteric fistula after prior aortic repair and primary fistula from diseased native aorta both demand immediate attention to hemodynamic control, infection control, and definitive reconstruction planning. Reviews of secondary fistula management emphasize that definitive treatment is surgical, with graft excision plus either extra-anatomic bypass or in-situ reconstruction and concurrent broad-spectrum antibiotics; endovascular repair may stabilize an unstable patient but should be viewed as a bridge when late sepsis risk remains. Secondary aortoenteric fistula

Endovascular control can save the exsanguinating patient, but it does not sterilize the field or repair the bowel problem. In primary aortoenteric fistula, endovascular repair achieves high initial stabilization but is followed by substantial rebleeding or reinfection and frequent conversion to open repair. Primary aortoenteric fistula Earlier pooled experience in aortoenteric fistula treated by stent-graft repair found persistent, recurrent, or new infection or bleeding in a large proportion of patients, with worse outcomes in preoperative sepsis and secondary fistula. Outcome after endovascular 2009

Secondary fistula after endovascular aortic intervention is rare but catastrophic. A systematic review described cases presenting after stent-graft placement with gastrointestinal bleeding or perigraft gas/fluid, and follow-up was too limited to draw strong durability conclusions. Secondary aortoenteric fistula 2008 A multicenter aortic endograft infection series found aortic fistula in 27% at presentation, reminding surgeons that endograft infection and fistula frequently intersect rather than existing as separate diagnoses. Treatment outcomes aortic 2016

Infected native aortic aneurysm requires the same disciplined separation of temporization and definitive therapy. A 2024 systematic review comparing treatment of infective native aortic aneurysm found higher pooled graft or endograft infection after endovascular treatment than after open surgery, although selection bias favors open repair in fitter patients. Analysis antibiotic strategies 2024 A contemporary endovascular series reported acceptable perioperative outcomes but measurable midterm recurrent aortic infection, supporting EVAR or TEVAR as a valuable option for selected high-risk or unstable patients while preserving skepticism about durability in an infected field. Midterm outcomes endovascular 2024

Counseling should be concrete. For a patient with fistula physiology or infected aneurysm, the surgeon should explain that endovascular therapy may control bleeding or rupture risk quickly, but later open conversion, persistent infection, recurrent bleeding, or lifelong antimicrobial decisions may follow. Contemporary secondary aortoenteric fistula and autologous in-situ reconstruction series add practical operative sequencing and conduit-choice experience, but the core decision remains patient fitness, contamination burden, fistula status, and whether durable source control is achievable. Case Series Secondary · Situ reconstruction autologous

13.5Follow-up is part of treatment selection

Follow-up begins before the operation because the chosen strategy determines the surveillance burden. Complete excision with in-situ reconstruction, extra-anatomic bypass, endovascular bridging, graft preservation, percutaneous drainage, and suppressive antibiotics all create different failure modes. The patient selected for retained prosthetic material or endovascular control in an infected field must be counseled that late recurrence, bleeding, reinfection, and antimicrobial toxicity are part of the treatment plan, not unexpected exceptions. Endograft Infection After 2017 · Aortic Endograft Infection

Late infection can emerge years after apparently successful aneurysm repair. A Finnish population-based study found similar long-term vascular graft infection incidence after open AAA repair and EVAR, but mortality among infected patients was substantial, especially when graft removal was not performed. Vascular Graft Infection 2023 This supports long-term vigilance after both open and endovascular repair rather than assuming that the endograft pathway is uniquely vulnerable or that open grafts become irrelevant after the early postoperative period.

Post-treatment surveillance should track the same domains used for diagnosis: symptoms, inflammatory trajectory, cultures when clinically indicated, graft or endograft anatomy, perigraft collections, and metabolic imaging when uncertainty remains. PET/CT can help when CT findings are ambiguous and may support response monitoring in infected native aortic aneurysm, but persistent postoperative uptake and lack of a single reliable SUV cutoff limit overconfident interpretation. F FDG PET 2022 · Value F-FDG-PET-CT management 2021 Imaging follow-up should therefore be linked to a management question: continue suppression, drain a collection, reoperate, convert from endovascular bridge to open repair, or accept palliation.

Failure modes should be anticipated by strategy. Endograft infection managed conservatively has high early mortality in pooled EVAR data, while endovascular treatment for fistula can stabilize bleeding yet carries substantial late rebleeding or reinfection. In-situ reconstruction may reduce reinfection compared with extra-anatomic bypass in abdominal graft infection, but morbidity, reintervention, and longer-term mortality remain significant. A clean discharge summary should therefore specify what was left behind, what organisms were treated, what imaging baseline was established, what antibiotic endpoint is intended, and what symptoms require immediate reassessment. Endograft Infection After 2017 · Outcomes Following Situ 2023 · Primary aortoenteric fistula

Antimicrobial follow-up is active vascular care. Delphi consensus bounds antimicrobial duration and emphasizes narrowing with operative cultures; outpatient parenteral antimicrobial therapy cohorts for aortic vascular graft infection highlight the intensity of line management and longitudinal antimicrobial decisions after discharge. Treatment follow-up vascular 2025 · Outpatient parenteral antimicrobial The surgeon should remain involved after the incision heals, because recurrent sepsis, line complications, persistent perigraft collection, or new bleeding may change the reconstructive plan.